new agents are under development to treat hepatitis b. many of these are nucleoside ucleotide analogues that investigators hope will be more effective than older agents. experts also are working on treatment guidelines and the use of multi-drug therapy. vaccination remains the key to preventing hepatitis b and holds the most promise for reducing disease burden.
what is new in the treatment of hepatitis b virus?